Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review
Previous case reports have described esophagitis thought to be secondary to crizotinib, an oral tyrosine-kinase inhibitor used in the treatment of anaplastic lymphoma kinase- (ALK-) positive non-small cell lung cancer (NSCLC). In those reports, the interval development of esophagitis was between two...
Saved in:
Main Authors: | Patrick Jung, Kyle J. Fortinsky, Zane R. Gallinger, Piero Tartaro |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Gastrointestinal Medicine |
Online Access: | http://dx.doi.org/10.1155/2016/3562820 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature
by: Kyle Kreitman, et al.
Published: (2020-01-01) -
Cloxacillin: A New Cause of Pill-Induced Esophagitis
by: Petros Zezos, et al.
Published: (2016-01-01) -
Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment
by: Gregory W. Charville, et al.
Published: (2018-01-01) -
Ventricular Tachycardia Induced by Weight Loss Pills
by: Manan Pareek, et al.
Published: (2013-01-01) -
Iron Pill-Induced Gastritis in the Paediatric Population
by: Daniel Ching, et al.
Published: (2019-01-01)